PRENW
Prenetics Global Limited
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.022
- Prev close
- 0.0093
- Mkt cap
- 257.24M
- Vol
- 100
- Avg vol
- 0
- EPS
- -11.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0089
- High
- 0.0093
- Forward P/E
- 0.00
- Beta
- -0.21
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -11.04
- Beta
- -0.21
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -219.78%
- Revenue (TTM)
- 22.66M
- Revenue growth
- 4.30%
- Free cash flow
- 0
- Total cash
- 63.89M
- Total debt
- 2.36M
- Return on equity
- -21.67%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Prenetics Global Limited
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. Additionally, it is involved in the sports distribution activities providing sports nutrition products to fitness facilities. The company operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Hong Kong
- Website
- prenetics.com
News
Your note
Sign in to keep a note on PRENW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Aspex Management (HK) Ltd | 10.31% | 1,166,666 | 13.07K | Sep 29, 2024 |
| Nine Masts Capital Ltd. | 3.20% | 362,456 | 4.06K | Sep 29, 2024 |
| Citadel Advisors Llc | 2.92% | 330,648 | 3.70K | Sep 29, 2024 |
| Walleye Capital LLC | 1.94% | 219,256 | 2.46K | Sep 29, 2024 |
| Calamos Advisors LLC | 1.77% | 200,000 | 2.24K | Sep 29, 2024 |
| Sona Asset Management (US) LLC | 1.65% | 186,538 | 2.09K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RiverNorth Opportunities Fd | 0.07% | 7,982 | 89 | Sep 29, 2024 |
| RiverNorth Capital & Income Fund, Inc. | 0.03% | 3,677 | 41 | Sep 29, 2024 |
| First Tr Exchange Traded Fd-First Trust Alternative Opportunities Fd | 0.00% | 479 | 5 | Sep 29, 2024 |